Latest News about CBAY
Recent news which mentions CBAY
   Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment Production
   
  
  
  March 15, 2024
  From Benzinga
 
   Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
   
  
  
  March 14, 2024
  From Benzinga
 
   CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
   
  
  
  February 13, 2024
  From Benzinga
 
   Fear & Greed Index Remains In 'Extreme Greed' Zone Ahead Of Inflation Data; Dow Hits Record high
   
  
  
  February 13, 2024
  From Benzinga
 
   Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
   
  
  
  February 12, 2024
  From Benzinga
 
   Why is CymaBay (CBAY) Stock Up 25% Today?
   
  
  
  February 12, 2024
  From InvestorPlace
 
   CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
   
  
  
  February 12, 2024
  From Benzinga
 From Benzinga
 
   Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
   
  
  
  February 12, 2024
  From Benzinga
 
   Raymond James Maintains Strong Buy Rating for CymaBay Therapeutics: Here's What You Need To Know
   
  November 08, 2023
  Tickers 
   CBAY
  
  
  From Benzinga
 
   Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today
   
  October 23, 2023
  Tickers 
   CBAY
  
  
  From Motley Fool
 
   7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio
   
  
  
  September 27, 2023
  From InvestorPlace
 
   Why CymaBay Therapeutics Stock Is Sinking This Week
   
  September 21, 2023
  Tickers 
   CBAY
  
  
  From Motley Fool
 
   Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
   
  
  
  September 21, 2023
  From Benzinga
 
   Why CymaBay Therapeutics Stock Triumphed Again on Tuesday
   
  September 12, 2023
  Tickers 
   CBAY
  
  
  From Motley Fool
 
   Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
   
  
  
  September 08, 2023
  From Benzinga
 
   Why CymaBay Therapeutics Stock Is Jumping Today
   
  
  
  September 08, 2023
  From Motley Fool
 
   Smartsheet, Kroger, Lantronix And Other Big Stocks Moving Higher On Friday
   
  
  
  September 08, 2023
  From Benzinga
 
   CymaBay Therapeutics' Lead Drug Candidate Hits Main Goal In Pivotal Study For Liver Damage
   
  September 07, 2023
  Tickers 
   CBAY
  
  
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  September 07, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
   
  
  
  August 14, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
   
  
  
  August 11, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.